Brief: Bellus Health Announces Positive Top-Line Phase 1 Results For Its Chronic Cough Drug

BELLUS Health

19/11/2018 22:50

Nov 19 (Reuters) - BELLUS Health Inc  BLU.TO :
    * BELLUS HEALTH ANNOUNCES POSITIVE TOP-LINE PHASE 1 RESULTS
FOR
ITS CHRONIC COUGH DRUG CANDIDATE BLU-5937
    * BELLUS HEALTH INC - BLU-5937 IS SHOWN TO BE SAFE AND WELL
TOLERATED
    * BELLUS HEALTH INC - INTENDS TO INITIATE A CLINICAL PHASE 2
STUDY
IN MID-2019; TOP-LINE RESULTS EXPECTED IN MID-2020
    * BELLUS HEALTH INC - THERE WERE NO SERIOUS ADVERSE EVENTS
AND NO
SUBJECTS WITHDREW PREMATURELY DUE TO AN ADVERSE EVENT DURING
STUDY

Source text for Eikon:  ID:nGNX9KMjQG 
Further company coverage:  BLU.TO 

 ((Reuters.Briefs@thomsonreuters.com;))